Last update 15 Jul 2025

ARUK2002821

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
PIP4K2A
Action
inhibitors
Mechanism
PIP4K2A inhibitors(phosphatidylinositol-5-phosphate 4-kinase type 2 alpha inhibitors)
Therapeutic Areas
Immune System DiseasesNervous System Diseases
Active Indication-
Inactive Indication
Autoimmune Diseases of the Nervous System
Originator Organization
University of CambridgeUniversity of Cambridge
Active Organization-
Inactive Organization
Cambridge, Inc.
License Organization-
Drug Highest PhaseDiscontinuedPreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with ARUK2002821
Login to view more data
100 Translational Medicine associated with ARUK2002821
Login to view more data
100 Patents (Medical) associated with ARUK2002821
Login to view more data
1
Literatures (Medical) associated with ARUK2002821
RSC medicinal chemistry
Identification of ARUK2002821 as an isoform-selective PI5P4Kα inhibitor
100 Deals associated with ARUK2002821
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Autoimmune Diseases of the Nervous SystemPreclinical
United Kingdom
Cambridge, Inc.
17 Apr 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free